Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer

David D Yang1,2,3, Aya Abdelnaser2, Alexander J Haas2,3

  • 1Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts.

Summary

Computational pathology reveals immune spatial clustering as a novel biomarker for prostate cancer (PCa) risk stratification. This interpretable approach identifies immune features linked to reduced distant metastasis risk in high-grade PCa.

Related Concept Videos